NCT06332794

Brief Summary

The goal of this mixed methods, user research study is to evaluate the Keep On Keep Up programme for people with Parkinson's (KOKU4PD). The main aims of the study are to:

  1. 1.To explore the usability and acceptability of the PD specific KOKU programme from a user and health care professional perspective.
  2. 2.To produce a KOKU4PD digital program that is ready for National Health Service (NHS) approval and a future effectiveness evaluation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 27, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 3, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

March 20, 2024

Last Update Submit

April 23, 2024

Conditions

Keywords

ExerciseFalls preventionTechnologyPhysical activityCo-design

Outcome Measures

Primary Outcomes (1)

  • Usability of the KOKU app

    Participants will be asked to complete questionnaires about the usability of the KOKU app and participate in an interview based on their responses to the questionnaires.

    After 4 weeks of using KOKU at home

Secondary Outcomes (11)

  • Executive clock drawing task (CLOX 1, 2) (mean Change from baseline)

    After 4 weeks of using KOKU at home

  • Trail Making Test (mean Change from baseline)

    After 4 weeks of using KOKU at home

  • Freezing of Gait Questionnaire (mean Change from baseline)

    After 4 weeks of using KOKU at home

  • Falls Efficacy scale (mean Change from baseline)

    After 4 weeks of using KOKU at home

  • Parkinson's disease quality of life questionnaire - PDQ-39 (mean Change from baseline)

    After 4 weeks of using KOKU at home

  • +6 more secondary outcomes

Study Arms (1)

KOKU user

EXPERIMENTAL

SIngle arm study - all participants will use the KOKU app for 4 weeks.

Device: KOKU4PD

Interventions

KOKU4PDDEVICE

Exercise at home using the KOKU app for 4 weeks.

KOKU user

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Parkinson's by a movement disorder specialist according to United Kingdom (UK) brain bank criteria (H\&Y stage I-III)
  • Able to walk and stand without support or assistance from another person
  • \>40 years
  • Stable medication for the previous 1 month and anticipated over a period of 6 months.
  • Adequate vision and hearing - to watch and use an iPad or Tablet.Aim: To define the study population/sample

You may not qualify if:

  • Dementia (\<21 on Montreal Cognitive Assessment (MoCA) or as diagnosed according to the Movement Disorder Society guidelines
  • Orthopaedic or cardiothoracic ailments that preclude safe walking
  • Severe auditory or visual impairment,
  • Diagnosis of clinical depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northumbria University

Newcastle upon Tyne, Tyne & Wear, NE1 8ST, United Kingdom

Location

MeSH Terms

Conditions

Parkinson DiseaseMotor Activity

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2024

First Posted

March 27, 2024

Study Start

June 3, 2024

Primary Completion

March 1, 2025

Study Completion

June 30, 2025

Last Updated

April 24, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

IPD will only be available to members of the study team.

Locations